No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
BXRXQ Baudax Bio
- 0.000
- 0.000-90.00%
15min DelayClose Dec 30 15:59 ET
43.59Market Cap0.00P/E (TTM)
0.000High0.000Low303.31KVolume0.000Open0.000Pre Close0.30Turnover0.70%Turnover Ratio0.00P/E (Static)43.59MShares0.03452wk High0.00P/B43.58Float Cap0.00052wk Low--Dividend TTM43.58MShs Float14196.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.000Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Baudax Bio Files for Chapter 11 Bankruptcy Protection
CORRECTION: BioCryst Pharmaceuticals Ticker Is "BCRX
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Baudax Bio Says Poised To Initiate TI-168 Clinical Development Following Recent Shareholder Approval Of Corporate Actions Related To TeraImmune Acquisition
Heat List
US
Overall
Symbol
Price
% Chg
No Data
